KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Total Debt (2016 - 2025)

Merck (MRK) has disclosed Total Debt for 17 consecutive years, with $49.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Debt rose 32.95% to $49.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $49.3 billion, a 32.95% increase, with the full-year FY2025 number at $49.3 billion, up 32.95% from a year prior.
  • Total Debt was $49.3 billion for Q4 2025 at Merck, up from $41.4 billion in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $49.3 billion in Q4 2025 to a low of $26.4 billion in Q3 2021.
  • A 5-year average of $34.4 billion and a median of $34.5 billion in 2024 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: decreased 14.1% in 2021, then soared 32.95% in 2025.
  • Merck's Total Debt stood at $33.1 billion in 2021, then decreased by 7.28% to $30.7 billion in 2022, then grew by 14.22% to $35.1 billion in 2023, then rose by 5.87% to $37.1 billion in 2024, then skyrocketed by 32.95% to $49.3 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Total Debt are $49.3 billion (Q4 2025), $41.4 billion (Q3 2025), and $35.4 billion (Q2 2025).